Danish healthcare leader Novo Nordisk launched "Live Lighter" campaign in Baku to address obesity.
Obesity is linked to over 200 conditions. The new once-weekly GLP-1 medication contains semaglutide.
Manufactured in Denmark, it has international approvals.
Danish ambassador Ole Toft emphasized partnership importance.











